Predicción y previsión de precio de First Tracks Biotherapeutics Inc (TRAX)TRAXFirst Tracks Biotherapeutics Inc

Alphio's TRAX stock price prediction model matches the current First Tracks Biotherapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $41.12 (-0.12%). The 1-week path is $42.01 (+2.03%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

First Tracks Biotherapeutics (TRAX) appears to be a good buy right now, trading at $41.86 with a significant upside potential. Analysts have set price targets ranging from $57 to $95, indicating potential gains of 36% to 127% from the current price. The company has shown strong momentum with an 85.96% year-to-date increase, despite recent volatility. However, the main risk is its negative earnings per share of -0.95 reported in Q2 2026, which reflects ongoing financial challenges.

First Tracks Biotherapeutics Inc (TRAX) last closed at $41.17, losing -1.60%. These facts feed the 1-day and 1-week TRAX price prediction above.